Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients
First study of monkeypox infection in women provides new insights to inform public health response to ongoing outbreak
17 November 2022Neonicotinoid causes ASD-like symptoms in chicks, finds study
18 November 2022Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients
Patients with a type of breast cancer called HER2-positive are less likely to survive if their initial treatment fails to eradicate the tumor completely and they have high levels of immune cells called tumor infiltrating lymphocytes in the residual disease.
